Skip to main content
SpringerLink
Log in

Funds totalling $US200 million, pledged by some of the world's richest nations through the Global Alliance for Vaccines and Immunisations, have been earmarked for the purchase of new-generation rotavirus and pneumococcal vaccines,

  • News item
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. $200 Million for vaccines in developing world. Pharma Times: [1 page], 30 Nov 2006. Available from: URL: http://www.pharmatimes.com

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Funds totalling $US200 million, pledged by some of the world's richest nations through the Global Alliance for Vaccines and Immunisations, have been earmarked for the purchase of new-generation rotavirus and pneumococcal vaccines,. Pharmacoecon. Outcomes News 518, 10 (2006). https://doi.org/10.2165/00151234-200605180-00032

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200605180-00032

Keywords

Search

Navigation